CTRI/2024/03/064372Not yet recruitingUnknown
Evaluation of the Selective Metabolic Para Meters during Shodhananga Tailapana - An Observational Study - NI
KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Apparently healthy subjects undergoing Arohana krama Tailapana for Virechana karma.
- •Patients who are willing to give blood samples.
Exclusion Criteria
- •All patients contraindicated for Snehapana and Virechana karma.
- •Known case of Hypertension, Diabetes Mellitus, Irritable bowel Syndrome.
- •Pregnant and lactating women.
- •Any severe illness.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy - Assessment of biomarkers in FSHDHealthy volunteers. Later the protocol will be applied to Facioscapular humeral dystrophy and/or other muscular dystrophies in general.MedDRA version: 8.1Level: LLTClassification code 10011328Term: CreatineEUCTR2006-006776-37-NLRadboud University Nijmegen Medical Center
Not yet recruiting
Phase 2
Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopymuscle diseasemuscular dystrophy10028302NL-OMON30391niversitair Medisch Centrum Sint Radboud35
Active, not recruiting
Not Applicable
Metabolic Response Evaluation for an Individualization of Neoadjuvant Chemo- and Radiotherapy in Esophageal Adenocarcinoma - MUNICON-2This study will test an optimized therapy for patients with chemotherapy-resistent locally advanced adenocarcinomas at the gastro-esophageal junction.According to the protocol, patients should receive a neoadjuvant radiochemotherapy if the tumor is metabolically not responding to chemotherapy.EUCTR2005-004123-19-DEKlinikum rechts der Isar der Technischen Universitaet Muenchen
Recruiting
Not Applicable
The assessment of predictive factor for metabolic disease, atherosclerotic disease, and onset of cancer in a community-based Studymetabolic disease, atherosclerotic disease, and cancerJPRN-UMIN000018789Saiseikai Imabari hospital20,000
Recruiting
Not Applicable
Clinical significance of metabolite measurement in the perioperative period.DiabetesJPRN-UMIN000043638The university of Tokyo.90